MDNYSEServices-HospitalsFiscal year ends December 31

Pediatrix Medical Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$27.30−0.08 (-0.29%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2011 to 2025

10.9%+5.3 pts over 5 years

8.6%+54.6 pts over 5 years

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Revenue	-4.9%	-1.0%	+2.0%	–
Operating income	–	+6.5%	+16.3%	-9.4%
Net income	–	+35.6%	–	-6.9%
EPS, diluted	–	+34.9%	–	-5.9%

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	12.5%	-70.9%	20.3%
Return on assets	6.6%	-21.3%	7.5%
Current ratio	1.31	3.49	1.66
Debt to equity	0.62	–	0.69
Net debt to EBITDA	2.49×	–	0.96×
Interest coverage	9.1×	0.9×	5.8×
Diluted shares	93M	83M	85M

Return on equity split into margin, efficiency and leverage

Net margin8.6%

Asset turnover0.87×

Equity multiplier2.70×

Return on equity, FY202520.3%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	8.6%	0.87×	2.70×	20.3%
FY2024	-4.9%	0.92×	2.71×	-12.3%
FY2023	-3.0%	0.87×	2.62×	-6.9%
FY2022	3.4%	0.78×	2.84×	7.4%
FY2021	6.9%	0.63×	3.69×	15.9%
FY2020	-45.9%	0.46×	3.34×	-70.9%
FY2019	-84.2%	0.35×	2.20×	-65.3%
FY2018	15.6%	0.29×	1.92×	8.7%
FY2017	9.8%	0.58×	1.92×	11.0%
FY2016	10.2%	0.64×	1.90×	12.5%

Parsed from the XBRL in Pediatrix Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Dec 20, 2013
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MD.

Revenue growth0.5% · median 4.0%

Operating margin11.0% · median 11.4%

Net margin9.0% · median 2.1%

Advertisement
300 × 250